Neurones S.A. (EPA:NRO)

Neurones Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	810.35	741.18	665.38	579.88	524.49
Revenue Growth (YoY)	9.33%	11.39%	14.74%	10.56%	2.83%
Cost of Revenue	421.59	394.42	356.26	323.3	296.19
Gross Profit	388.76	346.76	309.12	256.58	228.3
Selling, General & Admin	287.11	248.58	215	174.75	154.44
Other Operating Expenses	6.62	7.58	6.49	5.38	6.94
Operating Expenses	310.93	272.06	236.89	194.93	176.41
Operating Income	77.83	74.69	72.22	61.64	51.89
Interest Expense	-1.82	-1.43	-1.7	-0.97	-1.02
Interest & Investment Income	11.85	5.92	1.66	1.15	1.02
Other Non Operating Income (Expenses)	0	-	-0.02	-	-0.21
EBT Excluding Unusual Items	87.86	79.18	72.16	61.83	51.68
Gain (Loss) on Sale of Investments	0.16	0.43	0.03	0	1.91
Gain (Loss) on Sale of Assets	0.03	0.83	0.06	-0.3	-0.09
Other Unusual Items	0.07	0.33	0.61	0.23	0.06
Pretax Income	88.11	80.77	72.86	61.76	53.56
Income Tax Expense	24.88	22.18	21.09	18.82	18.58
Earnings From Continuing Operations	63.23	58.58	51.77	42.94	34.99
Minority Interest in Earnings	-10.67	-9.17	-7.53	-5.23	-4.07
Net Income	52.56	49.41	44.24	37.71	30.92
Net Income to Common	52.56	49.41	44.24	37.71	30.92
Net Income Growth	6.37%	11.68%	17.34%	21.95%	0.39%
Shares Outstanding (Basic)	24	24	24	24	24
Shares Outstanding (Diluted)	24	24	24	24	24
Shares Change (YoY)	0.14%	0.10%	0.18%	-0.13%	-0.07%
EPS (Basic)	2.17	2.04	1.83	1.56	1.28
EPS (Diluted)	2.16	2.03	1.82	1.55	1.27
EPS Growth	6.40%	11.54%	17.42%	22.05%	0.13%
Free Cash Flow	72.35	54.09	44.36	57.92	60.1
Free Cash Flow Per Share	2.97	2.23	1.83	2.39	2.48
Dividend Per Share	1.300	1.200	1.100	1.000	-
Dividend Growth	8.33%	9.09%	10.00%	-	-
Gross Margin	47.97%	46.78%	46.46%	44.25%	43.53%
Operating Margin	9.60%	10.08%	10.85%	10.63%	9.89%
Profit Margin	6.49%	6.67%	6.65%	6.50%	5.90%
Free Cash Flow Margin	8.93%	7.30%	6.67%	9.99%	11.46%
EBITDA	86.92	82.72	79.57	69.42	59.79
EBITDA Margin	10.73%	11.16%	11.96%	11.97%	11.40%
D&A For EBITDA	9.09	8.02	7.35	7.78	7.91
EBIT	77.83	74.69	72.22	61.64	51.89
EBIT Margin	9.60%	10.08%	10.85%	10.63%	9.89%
Effective Tax Rate	28.24%	27.47%	28.95%	30.47%	34.68%
Revenue as Reported	810.35	741.18	665.38	579.88	524.49

Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.